Floatz logo

Fragmin

Veno-occlusive Disease

Jonsson Comprehensive Cancer CenterPhase 3Dormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Veno-occlusive Disease cohort.

Asset / SponsorPhaseRating
Ketorolac Tromethamine
Children's Blood and Cancer Center at Dell Children's Medical Center
Phase 4B

Same molecule, other indications

Fragmin is also rated in:

venous thromboembolismDormant
BBB
Indicative ·
73 / 100
View asset →
plasma cell myelomaDormant
BB
Indicative ·
64 / 100
View asset →
BleedingDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →